comparemela.com

Page 30 - Tdoc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Teladoc Health (NYSE:TDOC) PT Lowered to $38 00 at Citigroup

Teladoc Health (NYSE:TDOC – Get Rating) had its price objective decreased by Citigroup from $43.00 to $38.00 in a research note published on Thursday, The Fly reports. A number of other equities research analysts also recently weighed in on TDOC. StockNews.com began coverage on shares of Teladoc Health in a research note on Thursday, March […]

Steward Partners Investment Advisory LLC Trims Holdings in Teladoc Health, Inc (NYSE:TDOC)

Steward Partners Investment Advisory LLC cut its holdings in Teladoc Health, Inc. (NYSE:TDOC – Get Rating) by 16.5% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,111 shares of the health services provider’s stock after selling 811 shares during the quarter. Steward […]

Citigroup Lowers Teladoc Health (NYSE:TDOC) Price Target to $38 00

Teladoc Health (NYSE:TDOC – Get Rating) had its target price reduced by equities research analysts at Citigroup from $43.00 to $38.00 in a research note issued on Thursday, The Fly reports. Citigroup’s target price points to a potential upside of 3.12% from the company’s current price. A number of other equities analysts have also commented […]

Insider Selling: Teladoc Health, Inc (NYSE:TDOC) SVP Sells 1,000 Shares of Stock

Teladoc Health, Inc. (NYSE:TDOC – Get Rating) SVP Daniel Trencher sold 1,000 shares of Teladoc Health stock in a transaction that occurred on Friday, June 17th. The stock was sold at an average price of $29.12, for a total value of $29,120.00. Following the completion of the transaction, the senior vice president now directly owns […]

Teladoc Health, Inc (NYSE:TDOC) Given Average Rating of Hold by Analysts

Shares of Teladoc Health, Inc. (NYSE:TDOC – Get Rating) have received a consensus recommendation of “Hold” from the thirty-two brokerages that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, fifteen have given a hold rating and six have issued a buy rating on the company. […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.